If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
The recent discovery of miRNA and its wide applicability have sparked off a
lot of interest among researchers as well as commercial players. Owing to the
same, there are numerous clinical trials being organized all over the world in
order to assess the potential of miRNA in diverse fields such as Cancer, Asthma,
Heart disorders, Diabetes, Hepatitis etc. The report, “Global miRNA Market
Outlook to 2018” provides an in-depth analysis of the various aspects of miRNA
at the industry as well as the research front.
The market has been divided into three sections i.e., The Americas, Europe and
Asia Pacific. These regions have then been analyzed to draw patterns in terms of
research areas and applicability. A brief look at the market suggests that
cancer is the most researched topic and regions such as United States, United
Kingdom, France, Israel and China are the major players interested in evaluating
the role played by miRNA.
Most of the current research is focused on utilizing miRNA for diagnostic
purposes such as expression profiling, response evaluation and setting potential
biomarkers in diseases. Another application is in the field of therapeutics
where miRNA mimics and inhibitors are being applied to control gene translation
and consequently its expression.
After an exhaustive study of the industry, RNCOS has laid out the primary market
players. These players are working over a vast variety of products such as miRNA
extraction and purification kits, and miRNA mimics and inhibitors. There are
other players who are solely providing miRNA associated diagnostic services and
assessing their therapeutic potential.
Overall, even though the market is in its nascent stage at the moment, it is
expanding at an almost exponential rate. With new players entering the market,
increase in the number of collaborations and strong support from research
institutes, the miRNA market is bound to witness rampant diversification and
growth in the coming years.
1. Analyst View
2. Research Methodology
3. miRNA - An Introduction
4. miRNA Techniques
4.1 miRNA Purification
4.2 miRNA Labeling
4.3 miRNA Linear Amplification
4.4 miRNA Microarrays
4.5 miRNA qRT-PCR
4.6 miRNA Inhibition
5. Global miRNA Market Outlook to 2018
5.1 By Geography
5.1.1 The Americas
5.1.3 Asia Pacific (APAC)
6. Ongoing miRNA Research by Disease
6.2 Cardiovascular Diseases
6.3 Metabolic Diseases
7. Key Players
7.1 Mirna Therapeutics, Inc.
7.2 Rosetta Genomics, Ltd.
7.3 InteRNA Technologies B.V.
7.4 Santaris Pharma A/S
7.5 Regulus Therapeutics
7.6 miRagen Therapeutics
7.8 Sigma-Aldrich Corporation
7.9 Thermo Fisher Scientific Inc.
7.10 Agilent Technologies Inc.
7.11 Life Technologies Corporation
7.12 System Biosciences
List of Figures:
Figure 3-1: miRNA Biogenesis
Figure 5-1: Global - miRNA Market (Million US$), 2012-2018
Figure 5-2: Ongoing miRNA Research by Geography (%), 2013
Figure 5-3: The Americas - miRNA Market (Million US$), 2012-2018
Figure 5-4: The Americas - Ongoing miRNA Research by Disease (%), 2013
Figure 5-5: Europe - miRNA Market (Million US$), 2012-2018
Figure 5-6: Europe - Ongoing miRNA Research by Disease (%), 2013
Figure 5-7: Europe - Ongoing miRNA Research by Country (%), 2013
Figure 5-8: APAC - miRNA Market (Million US$), 2012-2018
Figure 5-9: APAC - Ongoing miRNA Research by Disease (%), 2013
Figure 5-10: APAC - Ongoing miRNA Research by Country (%), 2013
Figure 6-1: Ongoing miRNA Research by Disease (%), 2013
Figure 6-2: Cancer - Ongoing miRNA Research (%), 2013
List of Tables:
Table 4-1: miRNA Purification Products by Supplier
Table 4-2: miRNA Labeling Products by Supplier
Table 4-3: miRNA Linear Amplification Products by Supplier
Table 4-4: miRNA Microarray Products by Supplier
Table 4-5: miRNA qRT-PCR Products by Supplier
Table 4-6: miRNA Inhibition Products by Supplier
Table 5-1: The Americas - Ongoing miRNA Research (2013)
Table 5-2: Europe - Ongoing miRNA Research (2013)
Table 5-3: APAC - Ongoing miRNA Research (2013)
Table 6-1: miRNAs associated with Cancer
Table 6-2: miRNA associated with Cardiovascular Diseases
Table 6-3: miRNAs associated with Metabolic Disorders
Table 6-4: miRNAs associated with Hepatitis
Table 7-1: Mirna Therapeutics - miRNA Research Pipeline
Table 7-2: Rosetta Genomics - miRNA based Cancer Tests
Table 7-3: InteRNA - miRNA Research Pipeline
Table 7-4: Santaris Pharma - miRNA Research Pipeline
Table 7-5: Regulus Therapeutics - miRNA Research Pipeline
Table 7-6: miRagen - miRNA Research Pipeline
Table 7-7: Qiagen - miRNA Associated Product Line
Table 7-8: Sigma Aldrich - miRNA Associated Product Line
Table 7-9: Thermo Fisher - miRNA Associated Product Line
Table 7-10: Agilent - miRNA Associated Product Line
Table 7-11: Life Technology - miRNA Associated Product Line
Table 7-12: System Biosciences - miRNA Associated Product Line
Table 7-13: GeneCopoeia - miRNA Associated Product Line